To accelerate time-to-market for life-saving therapies, manufacturers must move toward data-driven Container Closure System (CCS) qualification. By leveraging high-precision, nondestructive testing, teams can ensure regulatory compliance and patient safety throughout the product lifecycle.

The Challenge: Biologic Sensitivity

Biologics (vaccines, monoclonal antibodies) are highly sensitive. Infinitesimal ingress of oxygen or microbes can trigger protein aggregation or loss of sterility. A CCS must be qualified with extreme rigor to maintain a robust barrier under all storage conditions.

1. Container Closure Integrity (CCI): Verifying that interfaces (vial/stopper or syringe/plunger) prevent the passage of microorganisms and gases.
2. Barrier Performance: Quantifying how materials limit water vapor and oxygen transmission—vital for lyophilized or liquid-stable drugs.
3. Mechanical Performance: Ensuring components like crimp seals and plunger rods withstand the physical rigors of the supply chain.
4. Stability Integration: Monitoring how aging affects seal integrity through real-time and accelerated stability programs.

Modern testing platforms generate high-fidelity data earlier in the R&D cycle, reducing the risk of late-stage failures.

• Nondestructive Leak Detection: Using vacuum and pressure decay methods, Labthink C690 Nondestructive Leak Detection systems detect micro-leaks in vials and syringes without damaging the sample.

• Comparative Barrier Analysis: Labthink’s C403 and C406 Oxygen/Water Vapor Transmission Combo Systems allow for simultaneous material testing, ensuring the best material match for moisture-sensitive biologics from day one.

• Mechanical Stress Testing: The Labthink C610 Series evaluates seal strength and plunger movement force, simulating high-speed filling lines and global transport stresses.

• Worst-Case Mapping: Identify failure points (e.g., oxygen ingress in pre-filled syringes) early and focus testing on these high-risk scenarios.
• Accelerated “Snapshots”: Pair thermal stress with nondestructive CCI testing to gain early confidence in long-term stability before two-year markers are reached.
• Platform Transferability: Standardize testing across vials, cartridges, and syringes using shared Labthink platforms to shorten qualification timelines for future pipeline products.

Data-Driven Confidence

Transition from subjective methods to high-precision, traceable platforms. Labthink provides the instrumentation necessary to ensure your qualification data is accurate, repeatable, and ready for regulatory scrutiny.